2h
Zacks.com on MSNUnited Therapeutics Stock Down Despite Q4 Earnings & Sales BeatUnited Therapeutics’ UTHR fourth-quarter 2024 earnings of $6.19 per share beat the Zacks Consensus Estimate of $6.10.
Morgan Stanley sees Nvidia (NASDAQ:NVDA) jolting Asian AI stock prices up by double-digits if the artificial intelligence ...
Nvidia's earnings call is today at 5 pm ET. NVDA stock heads into the report down 6% YTD. Analysts are monitoring guidance ...
Shares of Boston Beer ( SAM 4.22%) were breaking out today after the craft brewer and malt beverage maker beat top-line ...
Dillard's beat earnings expectations for Q4 2024 but faced a challenging retail environment with mixed results across product categories.
Coca-Cola's strong Q4 performance and expected 2025 growth are promising. Read more to see why I remain neutral on KO stock.
The Canadian Press on MSN20h
S&P/TSX composite rises, U.S. markets mixed as Nasdaq falls 1.4 per centCanada’s main stock index was down 150 points in late-morning trading, weighed down by losses in energy, base metal and ...
Argentina’s economy expanded more than expected in December, solidifying the country’s bounceback in the last quarter of the ...
A once-bullish strategy chief just slashed his bullish rating on US stocks, just weeks after saying to buy the dip. Here's ...
The S&P 500’s average return on Fridays in 2025 has been a little under -0.3%, making it the worst day of the week for stocks ...
Major U.S. equities indexes were mixed after a weak consumer confidence report and losses from several noteworthy tech firms.
Throw in the third filter of good performance history, and you have the spine of the criteria to narrow down to the best high-probability stocks that are likely to make it into the portfolio.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results